PALI
PALISADE BIO, INC.
NASDAQ · Healthcare · Biotechnology · US
$1.25
+1.63%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 139.64x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 1.79x
- Price / sales
- 435.68x
- Price / cash flow
- -11.98x
Enterprise value
- Enterprise value
- $92.7M
- EV / sales
- 185.34x
- EV / EBITDA
- -2.79x
- EV / EBIT
- -2.62x
- Market cap
- $217.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026